UBE4A
Basic information
Region (hg38): 11:118359600-118399211
Links
Phenotypes
GenCC
Source:
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- multiple congenital anomalies/dysmorphic syndrome (Limited), mode of inheritance: AR
- neurodevelopmental disorder with hypotonia and gross motor and speech delay (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with hypotonia and gross motor and speech delay | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 33420346 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder with hypotonia and gross motor and speech delay (2 variants)
- UBE4A-related disorder (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBE4A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 44 | 45 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 3 | 2 | 44 | 4 | 2 |
Variants in UBE4A
This is a list of pathogenic ClinVar variants found in the UBE4A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-118365083-G-A | Uncertain significance (May 27, 2022) | |||
11-118365090-C-A | Inborn genetic diseases | Uncertain significance (Feb 07, 2023) | ||
11-118365139-G-C | Inborn genetic diseases | Likely benign (Apr 05, 2024) | ||
11-118368652-A-C | Inborn genetic diseases | Uncertain significance (Apr 15, 2024) | ||
11-118368669-G-A | Inborn genetic diseases | Uncertain significance (Jun 22, 2021) | ||
11-118368726-C-T | Neurodevelopmental disorder with hypotonia and gross motor and speech delay | Likely pathogenic (Feb 02, 2023) | ||
11-118368727-G-A | Inborn genetic diseases | Uncertain significance (Mar 18, 2024) | ||
11-118369436-G-C | Inborn genetic diseases | Uncertain significance (Apr 22, 2022) | ||
11-118369445-G-C | Likely benign (Jan 01, 2023) | |||
11-118369462-G-A | Inborn genetic diseases • UBE4A-related disorder | Uncertain significance (Sep 28, 2021) | ||
11-118369511-G-A | Neurodevelopmental disorder with hypotonia and gross motor and speech delay | Pathogenic (Mar 14, 2024) | ||
11-118371581-C-T | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
11-118371624-T-A | Likely benign (Jan 01, 2023) | |||
11-118372571-A-G | UBE4A-related disorder | Uncertain significance (Dec 15, 2023) | ||
11-118372576-C-T | Neurodevelopmental disorder with hypotonia and gross motor and speech delay | Pathogenic (Mar 07, 2019) | ||
11-118372585-C-T | Inborn genetic diseases | Uncertain significance (Aug 04, 2021) | ||
11-118372659-G-C | UBE4A-related disorder | Uncertain significance (Dec 15, 2023) | ||
11-118372686-C-G | Inborn genetic diseases | Likely benign (Oct 13, 2023) | ||
11-118373103-G-C | Inborn genetic diseases | Uncertain significance (Jul 12, 2022) | ||
11-118373197-G-C | Inborn genetic diseases | Uncertain significance (Jul 13, 2022) | ||
11-118373250-A-G | Inborn genetic diseases | Uncertain significance (Mar 20, 2023) | ||
11-118373253-C-A | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
11-118373282-G-A | Inborn genetic diseases | Uncertain significance (Aug 02, 2022) | ||
11-118373524-C-G | not specified | Uncertain significance (May 06, 2024) | ||
11-118373558-TG-T | UBE4A-related disorder | Pathogenic (Jan 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UBE4A | protein_coding | protein_coding | ENST00000431736 | 19 | 39627 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.109 | 0.891 | 125727 | 0 | 17 | 125744 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.21 | 436 | 587 | 0.743 | 0.0000312 | 7149 |
Missense in Polyphen | 90 | 183.05 | 0.49168 | 2289 | ||
Synonymous | 1.35 | 180 | 205 | 0.880 | 0.00000984 | 1993 |
Loss of Function | 5.11 | 13 | 53.3 | 0.244 | 0.00000300 | 601 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000178 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000937 | 0.0000924 |
European (Non-Finnish) | 0.0000706 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases. May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase. Mediates 'Lys-48'-linked polyubiquitination of substrates. {ECO:0000250|UniProtKB:E9Q735, ECO:0000250|UniProtKB:P54860}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0990
Intolerance Scores
- loftool
- 0.600
- rvis_EVS
- -1.09
- rvis_percentile_EVS
- 7.15
Haploinsufficiency Scores
- pHI
- 0.206
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.869
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ube4a
- Phenotype
Gene ontology
- Biological process
- protein polyubiquitination;ubiquitin-dependent protein catabolic process;ubiquitin-dependent ERAD pathway
- Cellular component
- ubiquitin ligase complex;nucleus;cytoplasm
- Molecular function
- protein binding;ubiquitin-ubiquitin ligase activity